T
TiumBio Co Ltd
KOSDAQ:321550
TiumBio Co Ltd
KOSDAQ:321550
Price:
6 400
KRW
13.68%
Market Closed
Market Cap:
₩186.1B
TiumBio Co Ltd
Goodwill
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
TiumBio Co Ltd
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
TiumBio Co Ltd
KOSDAQ:321550
|
Goodwill
₩1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Goodwill
₩11.7T
|
CAGR 3-Years
567%
|
CAGR 5-Years
422%
|
CAGR 10-Years
129%
|
|
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Goodwill
₩0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
TiumBio Co Ltd
Glance View
TiumBio Co., Ltd. engages in the development and manufacture of therapeutic drugs. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2019-11-22. The firm researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.
Intrinsic Value
5 751.85
KRW
Overvaluation 10%
T
See Also
What is TiumBio Co Ltd's Goodwill?
Goodwill
1.3B
KRW
1.3B
KRW
Based on the financial report for Dec 31, 2024, TiumBio Co Ltd's Goodwill amounts to 1.3B KRW.
